Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure

• Authors: PERUSINI MA.; PAGNANO K.; PAVLOVSKY C.; PAGNANO K.; MOIRAGHI B.; VARELA AI.; BIANCHINI M.; MAYER Jiří; ŽÁČKOVÁ Daniela; KVETKOVÁ Anežka; JURČEK Tomáš; JEŽÍŠKOVÁ Ivana; LOPES ABP.; DUARTE G.; SOUZA CA.; MEDEIROS J.; KIM TS.; YOO YS.; KIM KH.; LEE HW.; CHANG MH.; YI SY.; ABELSON S.; KIM D.
• Year of publication: 2022
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine